BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Hope Soars at ESMO 2021 for Breast Cancer Treatments

  Patients with different forms of breast cancer could soon have different treatment options following multiple presentations at the European Society of Medical Oncology meeting.

  September 20, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Investment in Biopharma is Reaching an Inflection Point

  During the past two years, fundraising and investment in biotechnology have reached record levels.

  September 20, 2021

   · 

  6 min read

   · 

  BioSpace Editorial Staff
• 

  Business

  Zai Lab to Increase US Presence with New Location in Cambridge

  Zai Lab Limited calls itself a growing global biopharmaceutical company and is continuing to live up to that claim with its latest expansion announcement.

  September 20, 2021

   · 

  1 min read

   · 

  Ellen Bombela
• 

  Business

  Former Novartis Exec Joins MiroBio to Fight Autoimmune Disease

  MiroBio’s pipeline involves checkpoint receptor pathways, not for immuno-oncology indications, but for the treatment of autoimmune diseases.

  September 20, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Pfizer-BioNTech Vaccine Found Safe and Effective in Kids Aged 5 to 11

  The Phase II/III trial showed a favorable safety profile and “robust” neutralizing antibody responses in children five to 11 years old who received two 10 µg doses of the vaccine at 21 days apart.

  September 20, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Study: The Key to Weight Loss May Lie in Your Gut Microbiome

  Researchers from the Institute for Systems Biology observed 105 participants and found that failing or succeeding at shedding pounds is linked to one’s gut microbiome.

  September 20, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Women-Led Jeito Capital Closes on $630 Million Life Sciences Investment Fund

  It is the largest venture capital fund in Europe focused on the life sciences.

  September 20, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Several Companies Tout Lung Cancer Breakthroughs at ESMO 2021

  Lung cancer is a particularly difficult cancer to treat, but several companies presented very promising data at this year’s European Society of Medical Oncology (ESMO) Congress 2021.

  September 20, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Protagonist’s PV Drug Placed on Hold After Mice Develop Tumors

  The company announced Friday that clinical studies have been placed on hold following the development of tumors in mice in a non-clinical study.

  September 20, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Drug Development

  With New CEO at the Helm, Mirati Presents Positive Colorectal Cancer Data

  Mirati Therapeutics tapped David Meek, the former chief executive officer of Ipsen, as its new CEO. He replaces company founder Charles Baum.

  September 20, 2021

   · 

  2 min read

   · 

  Alex Keown